Company
The Hash Corp
Headquarters: Toronto, ON, Canada
CEO: Chris Savoie
CSE: REZN
The Hash Corp Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019. The Hash Corporation was incorporated in 1967 and is headquartered in Toronto, Canada.
Stocks & Indices
The Hash Corp has the following listings and related stock indices.
Stock: CSE: REZN wb_incandescent